Completed
A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive Cancer
NCT06840548
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- ASST Papa Giovanni XXIII Bergamo, BG, Italy
- IRCCS Ospedale San Raffaele Milan, Milano, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Milano, Italy